-
Arch Capital Group Reports Mixed Earnings (ACGL)
Monday, October 25, 2010 - 3:20pm | 109Arch Capital Group Ltd. (NASDAQ: ACGL) reports Q3 earnings of $2.55 versus consensus of $2.36. Arch Capital Group Ltd. reports revenues of $636.1 million versus consensus of $694.73 million. Revenues fell 12.5% year over year. The company's book value per common share was $89.24 at September 30,...
-
Arch Capital Group Ltd. Reports Third Quarter Results; EPS $2.77
Monday, October 25, 2010 - 3:16pm | 85Arch Capital Group Ltd. (NASDAQ: ACGL) reports that net income available to common shareholders for the 2010 third quarter was $141.6 million, or $2.77 per share, compared to $274.4 million, or $4.39 per share, for the 2009 third quarter. The Company also reported after-tax operating income...
-
Platinum Underwriters Reports Strong Quarter (PTP)
Wednesday, October 20, 2010 - 4:07pm | 33Platinum Underwriters Holdings Ltd. (NYSE: PTP) reports Q3 earnings of $2.13 versus consensus of $1.39. Platinum Underwriters Holdings Ltd. reports revenues of $292.4 million versus consensus of $242.73 million.
-
Platinum Underwriters Holdings, Ltd. Reports Financial Results; EPS $2.13
Wednesday, October 20, 2010 - 3:23pm | 133Platinum Underwriters Holdings, Ltd. (NYSE: PTP) today reported net income of $93.7 million and diluted earnings per common share of $2.13 for the quarter ended September 30, 2010. Results for the quarter ended September 30, 2010 are summarized as follows: Net income was $93.7 million and...
-
Wells Fargo Lowers Everest Re Group 2010 EPS Estimates
Thursday, October 14, 2010 - 11:27am | 99Tonight after the market close Everest Re Group, Ltd. (NYSE: RE) pre-announced that Q3 operating earnings will fall in the range of $2.55-2.75 per share, Wells Fargo reports. “We are lowering our Q3 EPS estimate to $2.60 (from $3.00) mainly to reflect higher catastrophe losses and lower investment...
-
Everest Re Group Downgraded to Equal Weight (RE)
Monday, October 11, 2010 - 1:18pm | 30Everest Re Group Ltd. (NYSE: RE) is downgraded to Equal Weight at Barclays. The shares of Everest Re are down 4.26% trading at $82.34.
-
Everest Re Group Joseph V. Taranto to Remain as Chairman and CEO
Monday, October 11, 2010 - 10:38am | 70The Board of Directors of Everest Re Group Ltd. (NYSE: RE) announced today that it has asked Joseph V. Taranto to reconsider his decision to retire and to remain as Chairman and Chief Executive Officer through December 31, 2012. The Board also announced that Mr. Ralph E. Jones III, President and...
-
Benzinga's Top Downgrades (PTP, MSFT, CS, K)
Monday, October 4, 2010 - 6:17am | 149Keefe Bruyette downgraded Platinum Underwriters Holdings Ltd (NYSE: PTP) from "outperform" to "market perform." PTP's shares closed at $42.67 on Friday. Platinum Underwriters' quarterly revenue fell 5.72% y/y. Goldman downgraded Microsoft Corporation (NASDAQ: MSFT) from "buy" to "neutral." MSFT's...
-
Flagstone Re Provides Initial Estimate of %52.5M for New Zealand Earthquake Loss
Thursday, September 30, 2010 - 3:44pm | 149Flagstone Reinsurance Holdings, S.A. (NYSE: FSR) announced today that its preliminary estimate of claims relating to its exposure to the earthquake in New Zealand is $52.5 million net of reinstatement premiums and retrocession. Flagstone's loss estimate is based on its proprietary modeling...
-
Maiden Holdings Announces Exchange of Warrants With Founding Shareholders (MHLD)
Monday, September 20, 2010 - 3:33pm | 144Maiden Holdings, Ltd. (Nasdaq: MHLD) today announced that it has entered into an agreement with its founding shareholders, Michael Karfunkel, George Karfunkel and Barry Zyskind, to exchange all of the outstanding warrants held by them for restricted Maiden common shares. The outstanding warrants,...
-
NASDAQ Stocks Hitting 52-Week Highs (RVBD, SVNT, HOOK, ACGL)
Wednesday, September 15, 2010 - 11:11am | 154Riverbed Technology Inc (NASDAQ: RVBD) shares jumped 3.47% to create a new 52-week high of $44.78. RVBD's quarterly revenue surged 38.70% y/y. Savient Pharmaceuticals Inc (NASDAQ: SVNT) shares gained 27.24% to touch a new 52-week high of $18.78. The Food and Drug Administration (FDA) has approved...
-
PartnerRe Ltd. Announces Repurchase Authorization of Up To 7 Million Shares
Wednesday, September 8, 2010 - 3:07pm | 91PartnerRe Ltd. (NYSE: PRE) today announced that its Board of Directors has approved a new share repurchase authorization up to a total of 7 million common shares, effective immediately. This replaces the prior authorization of 8 million common shares announced by the Company in February 2010. To...
-
Validus Holdings, Ltd. to Release Q3 2010 Financial Results
Tuesday, September 7, 2010 - 3:13pm | 64Validus Holdings, Ltd. (NYSE: VR) announced today that it plans to release its financial results for the quarter ended September 30, 2010, after the close of trading on the New York Stock Exchange on Thursday, November 4, 2010. The Company will hold a conference call for analysts and investors at...
-
Arch Capital Group Ltd. to Present at Barclays Conference
Wednesday, September 1, 2010 - 9:21am | 87Arch Capital Group Ltd. (Nasdaq: ACGL) today announced that John C.R. Hele, Executive Vice President and Chief Financial Officer of Arch Capital Group Ltd., is scheduled to present at the Barclays Capital Global Financial Services Conference in New York. The presentation will take place on...
-
Zacks #1 Rank Additions for Wednesday - Tale of the Tape
Wednesday, September 1, 2010 - 7:33am | 313Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: American Axle & Manufacturing Holdings Inc (AXL) Asbury Automotive Group, Inc (ABG) Chesapeake Utilities Corp (CPK) CNB Financial Corp (CCNE) Enstar Group Ltd (ESGR) View the entire Zacks #1 Rank List. ASBURY...